Broad Institute at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Broad Institute takes part in 4 sessions at CTAD 2026 in Boston. Its program centres on multi-omic data and AI for biomarker discovery, including foundation models for clinical trials. Its work also covers responders to lifestyle intervention in the FINGER study and a synaptic preservation signature in plasma.

Organization	CTAD 2026 Attendance
Broad Institute Cambridge, Massachusetts
broadinstitute.org Universities & institutes Biomedical research institute of MIT and Harvard studying the genomics and biology of disease, including Alzheimer's.	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue FINGERS-7B: A Multi-Omic Foundation Model for Precision Biomarker Discovery (P124) Digital assessment and AI · Blood and CSF biomarkers Talk Tue Nov 17 4:00pm Metabolic-Inflammatory Burden Identifies Attenuated Responders to Lifestyle Intervention and Supports GLP-1RA Combination-Trial Design: Evidence from the FINGER study Prevention and early disease Poster Wed Nov 18 7:15am–5:30pm Plasma Proteomics Identifies a Two-Signal Synaptic Preservation Signature Associated with Cognitive Benefit in the FINGER Trial (P194) Prevention and early disease · Blood and CSF biomarkers Poster Thu Nov 19 7:15am–5:00pm Clinical Trials Should Run Multi-Omic Foundation Models in the Loop (P370) Digital assessment and AI · Trial design and endpoints

Organization

CTAD 2026 Attendance

Broad Institute

Cambridge, Massachusetts

broadinstitute.org

Universities & institutes

Biomedical research institute of MIT and Harvard studying the genomics and biology of disease, including Alzheimer's.

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

FINGERS-7B: A Multi-Omic Foundation Model for Precision Biomarker Discovery (P124)

Digital assessment and AI · Blood and CSF biomarkers

Talk

Tue Nov 17
4:00pm

Metabolic-Inflammatory Burden Identifies Attenuated Responders to Lifestyle Intervention and Supports GLP-1RA Combination-Trial Design: Evidence from the FINGER study

Prevention and early disease

Poster

Wed Nov 18
7:15am–5:30pm

Plasma Proteomics Identifies a Two-Signal Synaptic Preservation Signature Associated with Cognitive Benefit in the FINGER Trial (P194)

Prevention and early disease · Blood and CSF biomarkers

Poster

Thu Nov 19
7:15am–5:00pm

Clinical Trials Should Run Multi-Omic Foundation Models in the Loop (P370)

Digital assessment and AI · Trial design and endpoints

Instantly find 20 buyers from Broad Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction